These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1905935)

  • 1. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.
    Bradley DS; Broen JJ; Cafruny WA
    Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
    Cafruny WA; Bradley SE; Rowland RR
    Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a- and IgG2b-specific polyclonal activation of B cells.
    Hu B; Even C; Plagemann PG
    Viral Immunol; 1992; 5(1):27-38. PubMed ID: 1610489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes.
    Li X; Hu B; Harty J; Even C; Plagemann PG
    Viral Immunol; 1990; 3(4):273-88. PubMed ID: 2076177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immunoglobulin isotype blood levels, splenic B-cell phenotypes, and spleen cell immunoglobulin gene expression in mice infected with lactate dehydrogenase-elevating virus.
    Hovinen DE; Bradley DS; Cafruny WA
    Viral Immunol; 1990; 3(1):27-40. PubMed ID: 1967527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
    Broen JB; Bradley DS; Powell KM; Cafruny WA
    Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.
    Anderson GW; Rowland RR; Palmer GA; Even C; Plagemann PG
    J Virol; 1995 Aug; 69(8):5177-85. PubMed ID: 7609091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.
    Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG
    Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus.
    Coutelier JP; Van Snick J
    Eur J Immunol; 1985 Mar; 15(3):250-5. PubMed ID: 3872215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice.
    Cafruny WA; Plagemann PG
    Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycans on the short ectodomain of the primary envelope glycoprotein play a major role in the polyclonal activation of B cells by lactate dehydrogenase-elevating virus.
    Plagemann PGW; Jones QA; Cafruny WA
    J Gen Virol; 2000 Sep; 81(Pt 9):2167-2175. PubMed ID: 10950973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
    McDonald TL; Donnelly T; Weber A; Quenette L
    Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activation after infection with lactate dehydrogenase-elevating virus.
    Markine-Goriaynoff D; Hulhoven X; Cambiaso CL; Monteyne P; Briet T; Gonzalez MD; Coulie P; Coutelier JP
    J Gen Virol; 2002 Nov; 83(Pt 11):2709-2716. PubMed ID: 12388806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.